NOVONIX Statistics
Total Valuation
NOVONIX has a market cap or net worth of $237.08 million. The enterprise value is $261.00 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 489.00 million shares outstanding. The number of shares has increased by 0.37% in one year.
Current Share Class | n/a |
Shares Outstanding | 489.00M |
Shares Change (YoY) | +0.37% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 374.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | 1.62 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 37.96 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.15, with a Debt / Equity ratio of 0.45.
Current Ratio | 6.15 |
Quick Ratio | 5.28 |
Debt / Equity | 0.45 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -13.60 |
Financial Efficiency
Return on equity (ROE) is -26.03% and return on invested capital (ROIC) is -12.73%.
Return on Equity (ROE) | -26.03% |
Return on Assets (ROA) | -12.22% |
Return on Capital (ROIC) | -12.73% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | 0.46 |
Taxes
Income Tax | -199,949 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.60% in the last 52 weeks. The beta is 1.55, so NOVONIX's price volatility has been higher than the market average.
Beta (5Y) | 1.55 |
52-Week Price Change | +2.60% |
50-Day Moving Average | 1.91 |
200-Day Moving Average | 2.02 |
Relative Strength Index (RSI) | 49.12 |
Average Volume (20 Days) | 57,969 |
Short Selling Information
Short Interest | 120,576 |
Short Previous Month | 66,497 |
Short % of Shares Out | 0.02% |
Short % of Float | 0.03% |
Short Ratio (days to cover) | 2.08 |
Income Statement
In the last 12 months, NOVONIX had revenue of $6.88 million and -$46.86 million in losses. Loss per share was -$0.10.
Revenue | 6.88M |
Gross Profit | 5.82M |
Operating Income | -51.01M |
Pretax Income | -46.45M |
Net Income | -46.86M |
EBITDA | -46.76M |
EBIT | -51.01M |
Loss Per Share | -$0.10 |
Full Income Statement Balance Sheet
The company has $47.13 million in cash and $71.73 million in debt, giving a net cash position of -$24.60 million or -$0.05 per share.
Cash & Cash Equivalents | 47.13M |
Total Debt | 71.73M |
Net Cash | -24.60M |
Net Cash Per Share | -$0.05 |
Equity (Book Value) | 158.07M |
Book Value Per Share | 0.32 |
Working Capital | 48.48M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$37.25 million and capital expenditures -$15.49 million, giving a free cash flow of -$52.74 million.
Operating Cash Flow | -37.25M |
Capital Expenditures | -15.49M |
Free Cash Flow | -52.74M |
FCF Per Share | -$0.11 |
Full Cash Flow Statement Margins
Gross Margin | 84.63% |
Operating Margin | -741.99% |
Pretax Margin | -684.50% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -688.11% |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.37% |
Shareholder Yield | -0.37% |
Earnings Yield | -19.77% |
FCF Yield | -22.24% |
Analyst Forecast
The average price target for NOVONIX is $4.00, which is 103.05% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $4.00 |
Price Target Difference | 103.05% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 77.41% |
EPS Growth Forecast (5Y) | 44.85% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NOVONIX has an Altman Z-Score of 0.2 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.2 |
Piotroski F-Score | 2 |